Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
03/2000
03/09/2000WO1999055873A3 Basb006 polynucleotide(s) and polypeptides from neisseria meningitis
03/09/2000DE19837230A1 Use of neurotrophin-4 as a therapeutic agent, especially for treating melanoma
03/09/2000CA2777661A1 Multicomponent vaccines
03/09/2000CA2342534A1 Neisseria meningitidis polypeptide, nucleic acid sequence and uses thereof
03/09/2000CA2341775A1 Inducible expression system
03/09/2000CA2341761A1 Novel polypeptide
03/09/2000CA2341754A1 Stem cells bearing an fgf receptor on the cell surface
03/09/2000CA2341705A1 Sequences characteristic of hypoxia-regulated gene transcription
03/09/2000CA2341544A1 Method of dna vaccination
03/09/2000CA2341518A1 Hypoxia regulated genes
03/09/2000CA2341308A1 Human latent transforming growth factor-.beta. binding protein 3
03/09/2000CA2341064A1 Novel ubiquitin ligases as therapeutic targets
03/09/2000CA2341061A1 Targeted adenovirus vectors for delivery of heterologous genes
03/09/2000CA2340938A1 Antibodies specific for bladder nuclear matrix proteins blca-1 to blca-6
03/09/2000CA2340617A1 Genes associated with neurotransmitter processing
03/09/2000CA2340596A1 Guanylate binding protein (gbp-1) as inhibitor of cell proliferation and molecular marker for the determination of the stage of cellular differentiation
03/09/2000CA2340592A1 Phelix: a testis-specific protein expressed in cancer
03/09/2000CA2340462A1 Ehrlichia canis 120-kda immunodominant antigenic protein and gene
03/09/2000CA2340325A1 Alginate capsules for use in the treatment of brain tumour
03/09/2000CA2340276A1 Adenoviruses deleted in the iva2, 100k and/or preterminal protein sequences
03/09/2000CA2249657A1 Novel compounds
03/08/2000EP0984068A2 Sequences of hepatitis c virus genotypes and their use as therapeutic and diagnostic agents
03/08/2000EP0984067A2 Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents
03/08/2000EP0983391A1 Method for diagnosing alzheimer disease
03/08/2000EP0983360A1 Smad7 and uses thereof
03/08/2000EP0983357A1 Modulators of tissue regeneration
03/08/2000EP0983355A1 TUMOUR SUPPRESSOR GENE DBCCR1 AT 9q32-33
03/08/2000EP0983354A2 Neurotrophic factor receptors
03/08/2000EP0983353A1 Methods and compositions for diagnosis and treatment of cancer
03/08/2000EP0983352A1 Prostate specific regulatory nucleic acid sequences and transgenic non-human animals expressing prostate specific antigen
03/08/2000EP0983293A1 Fadd-like anti-apoptotic molecules, methods of using the same, and compositions for and methods of making the same
03/08/2000EP0983291A1 Carbamate-derivatized nucleosides and oligonucleosides
03/08/2000EP0983078A1 SIALOADHESIN FAMILY 4 cDNA
03/08/2000EP0873491A4 Ceramic packing with channels for thermal and catalytic beds
03/08/2000CN1246892A Expression vectors containing accessory molecule ligand genes and their use for immunomodulation and treatment of malignancies and autoimmune disease
03/07/2000US6034219 Human macrophage antigen
03/07/2000US6034135 Delivering anionic macromolecule to cell
03/07/2000US6034072 Genetic engineering; anticancer, antitumor agent
03/07/2000US6034071 Anticancer agent
03/07/2000US6033910 Antisense inhibition of MAP kinase kinase 6 expression
03/07/2000US6033908 Packaging systems for human recombinant adenovirus to be used in gene therapy
03/07/2000US6033905 Gibbon ape leukemia virus-based retroviral vectors
03/07/2000US6033885 Integrative recombinant adenoviruses, preparation thereof and therapeutical uses thereof
03/07/2000US6033884 Delivering nucleic acid into a cell.
03/07/2000US6033872 Polynucleotides encoding a novel human 11cb splice variant
03/07/2000US6033857 Chromosome 13-linked breast cancer susceptibility gene
03/07/2000US6033856 Promoter of the cdc25B gene, its preparation and use
03/07/2000US6033847 InK4c-p18 and InK4d-p19, inhibitors of cyclin-dependent kinases CDK4 and CDK6, and uses thereof
03/07/2000US6033674 Method of treating cancer with a tumor cell line having modified cytokine expression
03/02/2000WO2000011478A1 Assays, methods and means for modulating nuclear localisation
03/02/2000WO2000011217A1 Compounds and methods for enhancing delivery of free polynucleotide
03/02/2000WO2000011207A1 USE OF mCRP FOR DELIVERY OF MATERIALS INTO CELLS
03/02/2000WO2000011202A1 Cationic complexes of polymer-modified adenovirus
03/02/2000WO2000011201A1 Targeted alphavirus and alphaviral vectors
03/02/2000WO2000011195A1 C-myc is activated by beta-catenin and tcf-4
03/02/2000WO2000011173A1 Leptin-related peptides
03/02/2000WO2000011165A1 ROLE OF HUMAN KIS (hKIS) AS AN INHIBITORY KINASE OF THE CYCLIN-DEPENDENT KINASE INHIBITOR P27. COMPOSITIONS, METHODS AND USES THEREOF TO CONTROL CELL PROLIFERATION
03/02/2000WO2000011162A1 Modulation of apoptosis with bid
03/02/2000WO2000011159A1 Pharmaceutical composition for treating or preventing diabetes or cancer, or the waardenburg syndrome
03/02/2000WO2000011155A1 Methods and compositions for genomic modification
03/02/2000WO2000011139A1 Cell population containing non-fetal hemangioblasts and method for producing same
03/02/2000WO2000011137A1 Acid labile cationic amphiphiles
03/02/2000WO2000011033A2 Expression and export of angiostatin and endostatin as immunofusins
03/02/2000WO2000011019A1 Conjugates of dna interacting groups with steroid hormones for use as nucleic acid transfection agent
03/02/2000WO2000011018A1 Conjugates of dna interacting groups with steroid hormones for use as nucleic acid transfection agents
03/02/2000WO2000011015A1 Secreted proteins and polynucleotides encoding them
03/02/2000WO2000011014A1 49 human secreted proteins
03/02/2000WO2000010613A2 Inhibition of smooth muscle cell migration by heme oxygenase 1
03/02/2000WO2000010612A1 Methods to enhance and confine expression of genes
03/02/2000WO2000010609A1 Targeting of molecules to large vessel endothelium using epcr
03/02/2000WO2000010604A1 Gene therapy for regulating smooth muscle cell tone
03/02/2000WO2000010603A1 Compositions and methods for protecting organs, tissue and cells from immune system-mediated damage
03/02/2000WO2000010588A2 Epidermal growth factor receptor antagonists for treating hypersecretion of mucus in the lungs
03/02/2000WO2000010583A1 Human histone deacetylase gene hd4
03/02/2000WO2000010578A1 STABLE HYPOXIA INDUCIBLE FACTOR-1 alpha AND METHOD OF USE
03/02/2000WO1999066879A3 Systemic immune activation method using nucleic acid-lipid complexes
03/02/2000WO1999060124A9 Differentiation-associated sequences and methods of use therefor
03/02/2000WO1999058552A3 Peptides that ellicit t, cellular immunity
03/02/2000WO1999057263A9 Modifying the expression of the fsh beta gene by homologous recombination
03/02/2000WO1999054465A3 Gene encoding syntaxin interacting protein
03/02/2000WO1999054449A3 Dyskerine and dyskerine coding dna molecule, vectors containing the same, antibodies against dyskerin and utilization of said elements
03/02/2000WO1999050411A3 Tumour-specific expression control region and the use thereof
03/02/2000WO1999047668A3 Nucleic acid which codes for tumor suppressor proteins, tumor suppressor proteins, a method for the production thereof, an antibody against tumor suppressor proteins, and the use of these substances
03/02/2000WO1999045108A3 Novel mechanically sensitive mammal potassium channel family activated by polyunsaturated fatty acids and their use particularly for screening medicines
03/02/2000WO1999042088A3 Method for the treatment of diseases or disorders of the inner ear
03/02/2000WO1999024578A3 Neisserial antigens
03/02/2000DE19839096A1 A cytokine-inducible gene and related protein useful for modulation of interferon gamma
03/02/2000DE19827457C1 Strukturprotein von AAV, seine Herstellung und Verwendung AAV structural protein, its preparation and use
03/02/2000DE19816894C1 SREBP-2-defiziente Zellinien SREBP-2-deficient cell lines
03/02/2000CA2341586A1 Targeting of molecules to large vessel endothelium using epcr
03/02/2000CA2341558A1 Compositions and methods for protecting organs, tissue and cells from immune system-mediated damage
03/02/2000CA2341516A1 Cationic complexes of polymer-modified adenovirus
03/02/2000CA2341309A1 Use of mcrp for delivery of materials into cells
03/02/2000CA2341017A1 Compounds and methods for enhancing delivery of free polynucleotide
03/02/2000CA2340929A1 Methods to enhance and confine expression of genes
03/02/2000CA2340884A1 49 human secreted proteins
03/02/2000CA2340616A1 Secreted proteins and polynucleotides encoding them
03/02/2000CA2340470A1 Leptin-related peptides
03/02/2000CA2340459A1 C-myc is activated by beta-catenin and tcf-4
03/02/2000CA2339800A1 Gene therapy for regulating smooth muscle cell tone
1 ... 725 726 727 728 729 730 731 732 733 734 735 736 737 738 739 740 741 742 743 744 745 ... 870